Success Stories: An Assistant Professor from China Secures EB-1A in the Field of Biotechnology With the Help of Our Unrivaled Efforts and PP Service

 

Client’s Testimonial:

“Thank you very much for the excellent and professional work! I really appreciate all your efforts and kind assistance in each step.”


On August 5th, 2023, we received another EB-1A (Alien of Extraordinary Ability) approval for an Assistant Professor in the Field of Biotechnologies (Approval Notice).


General Field: Biotechnologies

Position at the Time of Case Filing: Assistant Professor

Country of Origin: China

Approval Notice Date: August 5th, 2023

Processing Time: 1 month, 10 days (Premium Processing Requested)


Case Summary:

An assistant professor from China, holding a PhD in mechanical engineering, reached out to us for assistance in preparing an I-140 EB-1A (Alien of Extraordinary Ability) petition on her behalf. Upon her initial contact, we commenced a thorough assessment of her extensive experience and expertise within the field of biotechnologies. Subsequently, we executed the client-attorney agreement and committed ourselves to guiding her toward a successful EB-1A application.

Our objective was to emphasize her notable accomplishments in the petition to be submitted to USCIS for an evaluation of her qualifications. We provided a comprehensive overview of her research, which centers on microfluidics, and lab-on-a-chip technologies, and has significantly contributed to advancing national interests. Her biotechnological research addresses some of the most urgent challenges facing our nation and the global community, particularly the burden of diseases such as cancer. Her robust foundation in microfluidics, and lab-on-a-chip technologies has enabled her research to be exceptionally innovative, culminating in her success in fundamentally transforming these critical areas.

Besides, we noted the 13 peer-reviewed scientific articles she published. She has proven herself to be an accomplished scholar through the publication of original research in several reputable scientific venues. The fostering of discussion within these scientific venues is pivotal to producing additional research inquiries and discoveries that advance the field, so this publication history is a key indicator of her success in the field to date.

Since her work has regularly inspired and guided the work of her peers, it is obvious that she has produced highly applicable research in the field of biotechnologies. Thus, we recorded the 208 times her work was cited from 28 countries, highlighting the significance of her discoveries for fellow scholars. These researchers are located all over the world, demonstrating that her remarkable work has a global impact.

Moreover, we confirmed that peer review is an integral part of the scientific process, ensuring that published papers benefit from an expert and objective eye before publication. She has furnished 23 reviews for several publications. Her service as a peer reviewer clearly reflects her elevated position within the field.

To fortify her case even more, we supplied recommendation letters signed by four of her other renowned scholars in the area, verifying her original and revolutionary study, with one of them contributing the following statement:

“Taken together, [Client’s] records of publication and citation paint a picture of a scholar operating at the top of her field. As I intend to make clear throughout this letter, her research is also particularly valuable to the United States due to its implications for cardiovascular health. Although we have never collaborated directly, I am confident in my assessment of her as an eminent scholar of biotechnologies. It is my professional opinion that she is an invaluable asset both to her field and to the United States.”

We concluded that our client is an extremely valuable asset to the biotechnology community. Her research contributions demonstrate her expertise in micro-electromechanical systems, lab-on-a-chip systems, and micro/nanofabrication. She has exceeded expectations for researchers in her field. Her continued presence is vital for the biotechnology research community. We are pleased to announce that our client's EB-1A petition was approved just 1 month and 10 days after we filed her case. Special thanks to the Premium Processing service, a paid option offered by the USCIS that expedites the adjudication process. We thank our client for choosing the North America Immigration Law Group and giving us the opportunity to be a part of her success story.